Literature DB >> 20302320

Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.

Dianlu Jiang1, Xiangjun Li, Lin Liu, Gargey B Yagnik, Feimeng Zhou.   

Abstract

A forefront of the research on Alzheimer's disease (AD) is the interaction of amyloid beta (Abeta) peptides with redox metal ions (e.g., Cu(II), Fe(III), and Fe(II)) and the biological relevance of the Abeta-metal complexes to neuronal cell loss and homeostasis of essential metals and other cellular species. This work is concerned with the kinetic and mechanistic studies of the ascorbic acid oxidation reaction by molecular oxygen that is facilitated by Cu(II) complexes with Abeta(1-16), Abeta(1-42), and aggregates of Abeta(1-42). The reaction rate was found to linearly increase with the concentrations of Abeta-Cu(II) and dissolved oxygen and be invariant with high ascorbic acid concentrations. The rate constants were measured to be 117.2 +/- 15.4 and 15.8 +/- 2.8 M(-1) s(-1) at low (<100 muM) and high AA concentrations, respectively. Unlike free Cu(II), in the presence of AA, Abeta-Cu(II) complexes facilitate the reduction of oxygen by producing H(2)O(2) as a major product. Such a conclusion is drawn on the basis that the reaction stoichiometry between AA and O(2) is 1:1 when the Abeta concentration is kept at a much greater value than that of Cu(II). A mechanism is proposed for the AA oxidation in which the oxidation states of the copper center in the Abeta complex alternates between 2+ and 1+. The catalytic activity of Cu(II) toward O(2) reduction was found to decrease in the order of free Cu(II) > Abeta(1-16)-Cu(II) > Abeta(1-42)-Cu(II) > Cu(II) complexed by the Abeta oligomer/fibril mixture > Cu(II) in Abeta fibrils. The finding that Cu(II) in oligomeric and fibrous Abeta aggregates possesses considerable activity toward H(2)O(2) generation is particularly significant, since in senile plaques of AD patients the coexisting copper and Abeta aggregates have been suggested to inflict oxidative stress through the production of reactive oxygen species (ROS). Although Cu(II) bound to oligomeric and fibrous Abeta aggregates is less effective than free Cu(II) and the monomeric Abeta-Cu(II) complex in producing ROS, in vivo the Cu(II)-containing Abeta oligomers and fibrils might be more biologically relevant given their stronger association with cell membranes and the closer proximity of ROS to cell membranes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20302320      PMCID: PMC2878184          DOI: 10.1021/jp9095375

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  49 in total

1.  Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase.

Authors:  T D Rae; P J Schmidt; R A Pufahl; V C Culotta; T V O'Halloran
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

2.  A kinetic model for beta-amyloid adsorption at the air/solution interface and its implication to the beta-amyloid aggregation process.

Authors:  Dianlu Jiang; Kim Lien Dinh; Travis C Ruthenburg; Yi Zhang; Lei Su; Donald P Land; Feimeng Zhou
Journal:  J Phys Chem B       Date:  2009-03-12       Impact factor: 2.991

3.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.

Authors:  Vello Tõugu; Ann Karafin; Peep Palumaa
Journal:  J Neurochem       Date:  2008-03       Impact factor: 5.372

5.  Mechanistic studies of Cu(II) binding to amyloid-beta peptides and the fluorescence and redox behaviors of the resulting complexes.

Authors:  Nakul C Maiti; Dianlu Jiang; Andrew J Wain; Sveti Patel; Kim L Dinh; Feimeng Zhou
Journal:  J Phys Chem B       Date:  2008-06-21       Impact factor: 2.991

6.  Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.

Authors:  Rozena Baruch-Suchodolsky; Bilha Fischer
Journal:  Biochemistry       Date:  2009-05-26       Impact factor: 3.162

Review 7.  Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.

Authors:  Peter Faller; Christelle Hureau
Journal:  Dalton Trans       Date:  2008-11-26       Impact factor: 4.390

8.  Pleomorphic copper coordination by Alzheimer's disease amyloid-beta peptide.

Authors:  Simon C Drew; Christopher J Noble; Colin L Masters; Graeme R Hanson; Kevin J Barnham
Journal:  J Am Chem Soc       Date:  2009-01-28       Impact factor: 15.419

9.  Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-beta peptide.

Authors:  Jesse W Karr; Veronika A Szalai
Journal:  Biochemistry       Date:  2008-04-05       Impact factor: 3.162

10.  Quantification of the binding constant of copper(II) to the amyloid-beta peptide.

Authors:  Lanying Q Hatcher; Lian Hong; William D Bush; Tessa Carducci; John D Simon
Journal:  J Phys Chem B       Date:  2008-06-18       Impact factor: 2.991

View more
  13 in total

Review 1.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.

Authors:  Colin L Masters; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

2.  Intraocular Oxygen and Antioxidant Status: New Insights on the Effect of Vitrectomy and Glaucoma Pathogenesis.

Authors:  Carla J Siegfried; Ying-Bo Shui
Journal:  Am J Ophthalmol       Date:  2019-02-15       Impact factor: 5.258

3.  Fate of model complexes with monocopper center towards the functional properties of type 2 and type 3 copper oxidases.

Authors:  Mariappan Murali; Velusamy Sathya; Balasubramaniam Selvakumaran
Journal:  J Biol Inorg Chem       Date:  2021-01-06       Impact factor: 3.358

4.  The Rich Electrochemistry and Redox Reactions of the Copper Sites in the Cellular Prion Protein.

Authors:  Feimeng Zhou; Glenn L Millhauser
Journal:  Coord Chem Rev       Date:  2012-05-04       Impact factor: 22.315

5.  The elevated copper binding strength of amyloid-β aggregates allows the sequestration of copper from albumin: a pathway to accumulation of copper in senile plaques.

Authors:  Dianlu Jiang; Lin Zhang; Gian Paola G Grant; Christopher G Dudzik; Shu Chen; Sveti Patel; Yuanqiang Hao; Glenn L Millhauser; Feimeng Zhou
Journal:  Biochemistry       Date:  2013-01-11       Impact factor: 3.162

6.  Aggregation pathways of the amyloid β(1-42) peptide depend on its colloidal stability and ordered β-sheet stacking.

Authors:  Dianlu Jiang; Iris Rauda; Shubo Han; Shu Chen; Feimeng Zhou
Journal:  Langmuir       Date:  2012-08-22       Impact factor: 3.882

7.  Copper redox cycling in the prion protein depends critically on binding mode.

Authors:  Lin Liu; Dianlu Jiang; Alex McDonald; Yuanqiang Hao; Glenn L Millhauser; Feimeng Zhou
Journal:  J Am Chem Soc       Date:  2011-07-18       Impact factor: 15.419

8.  Copper(II)-human amylin complex protects pancreatic cells from amylin toxicity.

Authors:  Elizabeth C Lee; Emmeline Ha; Sanghamitra Singh; Linda Legesse; Sana Ahmad; Elena Karnaukhova; Robert P Donaldson; Aleksandar M Jeremic
Journal:  Phys Chem Chem Phys       Date:  2013-08-14       Impact factor: 3.676

9.  Redox reactions of the α-synuclein-Cu(2+) complex and their effects on neuronal cell viability.

Authors:  Chengshan Wang; Lin Liu; Lin Zhang; Yong Peng; Feimeng Zhou
Journal:  Biochemistry       Date:  2010-09-21       Impact factor: 3.162

10.  Ascorbate Oxidation by Cu(Amyloid-β) Complexes: Determination of the Intrinsic Rate as a Function of Alterations in the Peptide Sequence Revealing Key Residues for Reactive Oxygen Species Production.

Authors:  Elena Atrián-Blasco; Melisa Del Barrio; Peter Faller; Christelle Hureau
Journal:  Anal Chem       Date:  2018-04-12       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.